Skip to content
healthcare.dev
Get a free key

Lumryz

NDC 13551-004, sodium oxybate, for suspension, extended release, from Alkermes, Inc..

Product NDC
13551-004
Status
Listed
Labeler
Alkermes, Inc.
Dosage form
FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214755
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13551-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM OXYBATE9 g/1

Pharmacologic classes

Central Nervous System Depressant [EPC]; Central Nervous System Depression [PE]; Decreased Central Nervous System Organized Electrical Activity [PE]

Package NDCNDC-11Package
13551-004-07135510004077 PACKET in 1 CARTON (13551-004-07) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET
13551-004-301355100043030 PACKET in 1 CARTON (13551-004-30) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/10e5e40c-52f3-4c73-8a34-2c29c690a934

Use it

Look up 13551-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13551-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13551-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.